266 results on '"Chaffanet M"'
Search Results
2. A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study
3. Author Correction: SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations
4. Publisher Correction: SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations
5. Molecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencing
6. SMCHD1 variants may induce variegated expression in Facio Scapulo Humeral Dystophy and Bosma Arhinia and microphtalmia syndrome
7. Isolation and Characterisation of NotI-end Cosmids Mapping to Human Chromosome 12p
8. Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth
9. Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias
10. Mutations of ASXL1 gene in myeloproliferative neoplasms
11. Genome profiling of acute myelomonocytic leukemia: alteration of the MYB locus in MYST3-linked cases
12. Gene expression profiling separates chronic myelomonocytic leukemia in two molecular subtypes
13. Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer
14. t(5;12)(q23–31;p13) with ETV6-ACSL6 gene fusion in polycythemia vera
15. PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation
16. Mutations and deletions of ARID1A in breast tumors
17. Gain of CBL-interacting protein, a possible alternative to CBL mutations in myeloid malignancies
18. Alterations of NFIA in chronic malignant myeloid diseases
19. Gain of CBL-interacting protein, a possible alternative to CBL mutations in myeloid malignancies
20. NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia
21. A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma
22. A major response to carboplatin in a metastatic triple-negative breast cancer patient with somatic mutation of BRCA1 and RAD51B: When chemotherapy meets precision medicine
23. Abstract P5-06-02: Ex vivo CSC assays for personalized testing of drug susceptibility in advanced breast cancer
24. Amplification and Expression of Viral Sequences and Oncogenes in Human Brain Tumors
25. Revisiting gene mutations and prognosis of ex-M6a-acute erythroid leukemia with regard to the new WHO classification
26. Abstract P4-13-23: Next-generation sequencing (NGS), array comparative genomic hybridization (aCGH) and patient-derived tumor xenograft (PDX) for precision medicine in advanced breast cancer: A single-center prospective study
27. 91P - A major response to carboplatin in a metastatic triple-negative breast cancer patient with somatic mutation of BRCA1 and RAD51B: When chemotherapy meets precision medicine
28. Molecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencing
29. Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia
30. 303 Genomic and epigenomic analysis identify potential therapeutic targets in luminal B breast cancer molecular subtype
31. Reciprocal translocations in breast tumor cell lines: Cloning of a t(3;20) that targets the FHIT gene
32. Early lesions of follicular lymphoma: a genetic perspective
33. Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase
34. Integrated profiling of basal and luminal breast cancers.
35. Abstract P5-03-01: Cancer stem cells predict engraftment and poor prognosis of primary breast tumors
36. 572 Integrated Genomic Analysis Identifies Candidate Genes in Luminal B Breast Cancer
37. Characterization of the Region of the Short Arm of Chromosome-8 Amplified in Breast-Carcinoma
38. Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms
39. Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes
40. Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias
41. The insulin-like growth factor receptor I status in luminal A breast carcinoma.
42. Alterations of NFIA in chronic malignant myeloid diseases
43. NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia
44. New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemias
45. Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer
46. P59: Breast cancer genomics reveals highly complex rearrangement patterns and opens the question of what events are essential
47. Multicolour-banding fluorescence in situ hybridisation (mbanding-FISH) to identify recurrent chromosomal alterations in breast tumour cell lines
48. Ancestrally-duplicated paraHOX gene clusters in humans.
49. Translocation and coamplification of loci from chromosome arms 8p and 11q in the MDA-MB-175 mammary carcinoma cell line.
50. Novel sequence tagged sites from the human 8p12-p21 chromosomal region involved in breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.